Nexien Biopharma, Inc. (NXEN) SEC Filing 10-K Annual report for the fiscal year ending Tuesday, June 30, 2020

Nexien Biopharma, Inc.

CIK: 1625288 Ticker: NXEN
Document and Entity Information - USD ($)
12 Months Ended
Jun. 30, 2020
Sep. 24, 2020
Dec. 31, 2019
Cover [Abstract]   
Entity Registrant NameNEXIEN BIOPHARMA, INC.  
Entity Central Index Key0001625288  
Document Type10-K  
Document Period End DateJun. 30, 2020  
Amendment Flagfalse  
Current Fiscal Year End Date--06-30  
Entity Well-known Seasoned IssuerNo  
Entity Voluntary FilersNo  
Entity Reporting Status CurrentYes  
Entity Interactive Data CurrentYes  
Entity Filer CategoryNon-accelerated Filer  
Entity Small Business Flagtrue  
Entity Emerging Growth Companytrue  
Entity Ex Transition Periodfalse  
Entity Shell Companyfalse  
Entity Public Float  $ 739,977
Entity Common Stock, Shares Outstanding 55,781,196 
Document Fiscal Period FocusFY  
Document Fiscal Year Focus2020  

View differences made from one year to another to evaluate Nexien Biopharma, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Nexien Biopharma, Inc..


Assess how Nexien Biopharma, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Nexien Biopharma, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: NXEN
CIK: 1625288
Form Type: 10-K Annual Report
Accession Number: 0001493152-20-018396
Submitted to the SEC: Mon Sep 28 2020 6:10:33 AM EST
Accepted by the SEC: Mon Sep 28 2020
Period: Tuesday, June 30, 2020
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: